ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

IVVD Invivyd Inc

1,77
0,02 (1,14%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Invivyd Inc IVVD NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,02 1,14% 1,77 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,75 1,69 1,80 1,69 1,75
mais cotações »

Notícias Recentes

Data Hora Fonte Título
03/06/202417:01GLOBEInvivyd to Participate at the Jefferies Global Healthcare..
31/05/202408:05GLOBEInvivyd Announces General Alignment with U.S. FDA on a..
31/05/202408:00GLOBEInvivyd Announces the Appointment of Timothy Lee as Chief..
29/05/202408:00GLOBEInvivyd to Present Data at 2024 American Society of Clinical..
22/05/202408:00GLOBEInvivyd Elects Two New Independent Members to its Board of..
13/05/202417:01GLOBEInvivyd to Participate at the H.C. Wainwright 2nd Annual..
09/05/202417:01GLOBEInvivyd Reports First Quarter 2024 Financial Results and..
07/05/202408:30GLOBEInvivyd to Pursue Rapid Immunobridging Pathway to Potential..
02/05/202418:13GLOBEInvivyd to Host Conference Call Discussing First Quarter..
30/04/202408:30GLOBEInvivyd Announces $20 Million to $25 Million Improvement in..
15/04/202408:30GLOBEInvivyd Receives Healthcare Common Procedure Coding System..
12/04/202408:30GLOBEInvivyd Announces CEO Transition
04/04/202417:01GLOBEInvivyd Provides PEMGARDA™ Launch Update and Announces 2024..
28/03/202408:00GLOBEInvivyd Reports Full Year 2023 Financial Results and Recent..
22/03/202416:28GLOBEInvivyd Announces Interim Exploratory Data on VYD222 from..
22/03/202416:04GLOBEInvivyd Announces FDA Authorization for Emergency Use of..
05/02/202418:02GLOBEInvivyd to Participate at the Guggenheim Healthcare Talks..
03/01/202409:00GLOBEInvivyd Submits Request for Emergency Use Authorization..
18/12/202309:00GLOBEInvivyd Announces Positive Initial Results from Ongoing..
09/11/202318:01GLOBEInvivyd Reports Third Quarter 2023 Financial Results and..
02/11/202317:01GLOBEInvivyd to Host Conference Call Discussing Third Quarter..
31/10/202317:01GLOBEInvivyd to Participate in Upcoming Investor Conferences
11/09/202308:00GLOBEInvivyd Announces Dosing of First Participant in CANOPY..
06/09/202308:00GLOBEInvivyd to Participate in Upcoming Investor Conferences
05/09/202308:00GLOBEInvivyd Appoints William Duke as Chief Financial Officer
10/08/202317:01GLOBEInvivyd Reports Second Quarter 2023 Financial Results and..
03/08/202317:01GLOBEInvivyd to Host Conference Call Discussing Second Quarter..
27/07/202317:01GLOBEInvivyd Announces Appointment of Sara Cotter to Board Of..
17/07/202308:00GLOBEInvivyd Announces Additional Positive Initial Data from..
26/06/202308:00GLOBEInvivyd Announces General Alignment with FDA on Pathway to..
22/06/202308:00GLOBEInvivyd Announces Positive Initial Data from Ongoing Phase 1..